Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment

Zhou Xiaoyu; Peng Changfu

doi:doi:10.11648/j.ijmi.20210902.11

| Peer-Reviewed

Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment

Zhou Xiaoyu, Peng Changfu

Published in International Journal of Medical Imaging (Volume 9, Issue 2)

Received: 5 April 2021 Accepted: 15 April 2021 Published: 23 April 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Because the affected parts of some tumors and diseases are generally hidden, some are deeper, and the tissue structure is more complex and diverse, misdiagnosis and missed diagnosis are very easy to occur in the process of clinical diagnosis. In addition, the development of various diseases and tumors is closely related to the quality of life and prognosis of patients. Therefore, the diagnosis and treatment of diseases and monitoring after treatment are particularly important for patients. Ultrasound is easy to operate, non-invasive, and can be observed in real time. Ultrasound is the most used Frequent imaging diagnostic tools. In recent years, contrast-enhanced ultrasound (CEUS), as a newly developed imaging technology, has made important progress in ultrasound examination. In particular, the second-generation microbubble (MB) contrast agent in contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice. It can observe the whole process of organ and tumor microcirculation blood perfusion in real time and continuously, not only The morphological characteristics of the lesion can also provide the blood flow characteristics of the lesion, which improves the ability of the ultrasonic diagnostic instrument to display the blood flow in the lesion. Due to its non-invasiveness, real-time and safety, contrast-enhanced ultrasound technology provides safe, effective and valuable diagnostic and treatment options for ophthalmology, liver, gastrointestinal tract, heart, pediatrics and other fields. This article briefly reviews the origin and development of contrast agent ultrasound, basic principles, safety, the application of contrast-enhanced ultrasound in clinical diagnosis and treatment, and the advantages and disadvantages of contrast-enhanced ultrasound, and discusses its future development and limitations for pre-clinical surgery The qualitative diagnosis, selection of surgical methods and prognostic judgment and evaluation provide more accurate and comprehensive information in order to better serve and treat clinical diagnosis.

Published in	International Journal of Medical Imaging (Volume 9, Issue 2)
DOI	10.11648/j.ijmi.20210902.11
Page(s)	98-103
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Contrast-enhanced Ultrasound, Ultrasound Contrast Agent, Clinical Application

References

[1]	王子杨,杨文利.眼科超声检查的发展现状及合理应用[J].国际眼科纵览, 2014, 38 (06): 375-379.
[2]	Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Die EFSUMB-Leitlinien und Empfehlungen für den klinischen Einsatz des kontrastverstärkten Ultraschalls (CEUS) bei nicht-hepatischen Anwendungen: Update 2017 (Langversion). Ultraschall Med. 2018; 39 (2): e2-e44.
[3]	章希睿, 张明博, 桑茂栋, 等.医学超声造影成像的新技术研究进展[J].中国生物医学工程学报, 2016, 35 (2): 225-233.
[4]	Claudon M, Cosgrove D, Albrecht T et al. Guidelines and Good ClinicalPractice Recommendations for Contrast Enhanced Ultrasound (CEUS) –Update 2008. Ultraschall in Medizin 2008; 29: 28-44.
[5]	Kaufmann BA, Lindner JR. Molecular imaging with target-ed contrast ultrasound. Curr Opin Biotechnol 2007; 18: 11-16 [PMID: 17241779.
[6]	Appis, A. W., Tracy, M. J., & Feinstein, S. B. (2015). Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications, Echo Research and Practice, 2 (2), R55-R62.
[7]	Nanda NC 1997 History of echocardiographic contrast agents. Clinical Cardiology 20, 7–11.
[8]	Feinstein SB, Shah PM, Bing RJ, Meerbaum S, Corday E, Chang BL, Santillan G & Fujibayashi Y 1984 Microbubble dynamics visualized in the intact capillary circulation. Journal of the American College of Cardiology 4 595–600.
[9]	Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA, Wilson S, Fane L, Herzog CA & Zoghbi WA 2008 The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. Journal of the American Society of Echocardiography 21 1202–1206.
[10]	Wever-Pinzon O, Suma V, Ahuja A, Romero J, Sareen N, Henry SA, De Benedetti Zunino M, Chaudhry FF, SuryadevaraRS & Sherrid MV 2012 Safety of echocardiographiccontrast in hospitalized patients with pulmonary hypertension: a multi-center study. European Heart Journal Cardiovascular Imaging 13857–862.
[11]	农美芬.超声造影在眼眶肿瘤诊断中的应用[J].微创医学, 2008 (05): 488-490.
[12]	郭佩琦,张昊,王燕霞,马刚,崔煜艳.超声造影联合荧光血管造影在脉络膜肿瘤诊断中的价值[J].临床超声医学杂志, 2016, 18 (10): 662-666.
[13]	Han SS, Chang SK, Yoon JH, Lee YJ. The use of contrast-enhancedcolor Doppler ultrasound in the differentiation of retinal detach-ment from vitreous membrane. Korean J Radiol 2001; 2: 197e203.
[14]	Bertolotto, M., Serafini, G., Sconfienza, L. M., Lacelli, F., Cavallaro, M., Coslovich, A., Tognetto, D., & Cova, M. A. (2014). The use of CEUS in the diagnosis of retinal/choroidal detachment and associated intraocular masses - preliminary investigation in patients with equivocal findings at conventional ultrasound. Ultraschall in der Medizin (Stuttgart, Germany: 1980), 35 (2), 173–180.
[15]	杨文利,魏文斌,李栋军.脉络膜黑色素瘤的超声造影诊断特征[J].中华眼科杂志, 2013 (05): 428-432.
[16]	Piscaglia F, Nolsoe C, Dietrich CF et al. The EFSUMB Guidelines and Re-commendations on the Clinical Practice of Contrast-enhanced Ultra-sound (CEUS): Update 2011 on non-hepatic applications. Ultraschallin Med 2012; 33: 33-59.
[17]	Ter Haar G. Safety and bio-effects of ultrasound contrast agents. MedBiol Eng Comput 2009; 47: 893-900.
[18]	Migaleddu V, Scanu AM, Quaia E et al. Contrast-Enhanced Ultrasono-graphic Evaluation of Inflammatory Activity in Crohn’s Disease. Gas-troenterology 2009; 137: 43–52.
[19]	Serra C, Menozzi G, Labate AM, Giangregorio F, Gionchetti P, Beltrami M, Robotti D. et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 2007; 62: 114-121.
[20]	赵慧,黄丽萍.超声在炎症性肠病中的应用进展[J].中国医学影像学杂志, 2020, 28 (09): 717-720.
[21]	Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, von Herbay A, Friedrich-Rust M. et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008; 29: 499-505.
[22]	Strobel D, Bernatik T, Blank W, Schuler A, Greis C, Dietrich CF, Seitz K. Diagnostic accuracy of CEUS in the differential diagnosis of small (< / = 20 mm) and subcentimetric (< / = 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med 2011; 32: 593-597.
[23]	章建全,陈佳彬,刘灿,蔡清萍,陈学云.经皮经肝穿刺胆道超声造影的方法及临床意义[J].中华超声影像学杂志, 2008 (06): 513-516.
[24]	谢晓燕,陈瑜君.超声造影的创新性应用[J].中国医学影像技术, 2019, 35 (11): 1601-1603.
[25]	李超伦,王文平.超声造影在评价颈动脉粥样硬化斑块稳定性方面的应用[J].中国临床医学, 2011, 18 (01): 109-111.
[26]	Darge K. Papadopoulu F. Ntoulia A. et al. Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr Radiol 2013; 43: 1063-1073.
[27]	Sidhu PS, Cantisani V, Deganello A, Dietrich CF, Duran C, Franke D, Harkanyi Z et al. Role of Contrast-Enhanced Ultrasound (CEUS) in Paediatric Practice: An EFSUMB Position Statement. Ultraschall Med 2016.
[28]	Linde HN. Holland A. Greene BH. et al. Kontrastunterstzte Sonografie (CEUS) bei Pneumonie: Darstellungsmuster und prognostische Bedeutung eine retrospektive Studie bei 50 Patienten. Ultraschall in Med 2012; 33: 146-151.
[29]	Durkin N. Deganello A. Sellars ME. et al. Post-traumatic liver and spleen pseudoaneurysms in children: diagnosis, management and follow-up screening using contrast enhanced ultrasound (CEUS). J Pediat Surg 2016; 51: 289-292.

Cite This Article

Plain Text BibTeX RIS

APA Style

Zhou Xiaoyu, Peng Changfu. (2021). Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment. International Journal of Medical Imaging, 9(2), 98-103. https://doi.org/10.11648/j.ijmi.20210902.11

Copy | Download

ACS Style

Zhou Xiaoyu; Peng Changfu. Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment. Int. J. Med. Imaging 2021, 9(2), 98-103. doi: 10.11648/j.ijmi.20210902.11

Copy | Download

AMA Style

Zhou Xiaoyu, Peng Changfu. Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment. Int J Med Imaging. 2021;9(2):98-103. doi: 10.11648/j.ijmi.20210902.11

Copy | Download

@article{10.11648/j.ijmi.20210902.11,
  author = {Zhou Xiaoyu and Peng Changfu},
  title = {Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment},
  journal = {International Journal of Medical Imaging},
  volume = {9},
  number = {2},
  pages = {98-103},
  doi = {10.11648/j.ijmi.20210902.11},
  url = {https://doi.org/10.11648/j.ijmi.20210902.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20210902.11},
  abstract = {Because the affected parts of some tumors and diseases are generally hidden, some are deeper, and the tissue structure is more complex and diverse, misdiagnosis and missed diagnosis are very easy to occur in the process of clinical diagnosis. In addition, the development of various diseases and tumors is closely related to the quality of life and prognosis of patients. Therefore, the diagnosis and treatment of diseases and monitoring after treatment are particularly important for patients. Ultrasound is easy to operate, non-invasive, and can be observed in real time. Ultrasound is the most used Frequent imaging diagnostic tools. In recent years, contrast-enhanced ultrasound (CEUS), as a newly developed imaging technology, has made important progress in ultrasound examination. In particular, the second-generation microbubble (MB) contrast agent in contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice. It can observe the whole process of organ and tumor microcirculation blood perfusion in real time and continuously, not only The morphological characteristics of the lesion can also provide the blood flow characteristics of the lesion, which improves the ability of the ultrasonic diagnostic instrument to display the blood flow in the lesion. Due to its non-invasiveness, real-time and safety, contrast-enhanced ultrasound technology provides safe, effective and valuable diagnostic and treatment options for ophthalmology, liver, gastrointestinal tract, heart, pediatrics and other fields. This article briefly reviews the origin and development of contrast agent ultrasound, basic principles, safety, the application of contrast-enhanced ultrasound in clinical diagnosis and treatment, and the advantages and disadvantages of contrast-enhanced ultrasound, and discusses its future development and limitations for pre-clinical surgery The qualitative diagnosis, selection of surgical methods and prognostic judgment and evaluation provide more accurate and comprehensive information in order to better serve and treat clinical diagnosis.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment
AU  - Zhou Xiaoyu
AU  - Peng Changfu
Y1  - 2021/04/23
PY  - 2021
N1  - https://doi.org/10.11648/j.ijmi.20210902.11
DO  - 10.11648/j.ijmi.20210902.11
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 98
EP  - 103
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20210902.11
AB  - Because the affected parts of some tumors and diseases are generally hidden, some are deeper, and the tissue structure is more complex and diverse, misdiagnosis and missed diagnosis are very easy to occur in the process of clinical diagnosis. In addition, the development of various diseases and tumors is closely related to the quality of life and prognosis of patients. Therefore, the diagnosis and treatment of diseases and monitoring after treatment are particularly important for patients. Ultrasound is easy to operate, non-invasive, and can be observed in real time. Ultrasound is the most used Frequent imaging diagnostic tools. In recent years, contrast-enhanced ultrasound (CEUS), as a newly developed imaging technology, has made important progress in ultrasound examination. In particular, the second-generation microbubble (MB) contrast agent in contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice. It can observe the whole process of organ and tumor microcirculation blood perfusion in real time and continuously, not only The morphological characteristics of the lesion can also provide the blood flow characteristics of the lesion, which improves the ability of the ultrasonic diagnostic instrument to display the blood flow in the lesion. Due to its non-invasiveness, real-time and safety, contrast-enhanced ultrasound technology provides safe, effective and valuable diagnostic and treatment options for ophthalmology, liver, gastrointestinal tract, heart, pediatrics and other fields. This article briefly reviews the origin and development of contrast agent ultrasound, basic principles, safety, the application of contrast-enhanced ultrasound in clinical diagnosis and treatment, and the advantages and disadvantages of contrast-enhanced ultrasound, and discusses its future development and limitations for pre-clinical surgery The qualitative diagnosis, selection of surgical methods and prognostic judgment and evaluation provide more accurate and comprehensive information in order to better serve and treat clinical diagnosis.
VL  - 9
IS  - 2
ER  -

Copy | Download

Author Information

Zhou Xiaoyu

Department of Medical College, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China
Peng Changfu

Center for Ophthalmic Optics, Hunan Provincial People's Hospital, Changsha, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Zhou Xiaoyu, Peng Changfu. (2021). Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment. International Journal of Medical Imaging, 9(2), 98-103. https://doi.org/10.11648/j.ijmi.20210902.11

Copy | Download

ACS Style

Zhou Xiaoyu; Peng Changfu. Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment. Int. J. Med. Imaging 2021, 9(2), 98-103. doi: 10.11648/j.ijmi.20210902.11

Copy | Download

AMA Style

Zhou Xiaoyu, Peng Changfu. Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment. Int J Med Imaging. 2021;9(2):98-103. doi: 10.11648/j.ijmi.20210902.11

Copy | Download

@article{10.11648/j.ijmi.20210902.11,
  author = {Zhou Xiaoyu and Peng Changfu},
  title = {Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment},
  journal = {International Journal of Medical Imaging},
  volume = {9},
  number = {2},
  pages = {98-103},
  doi = {10.11648/j.ijmi.20210902.11},
  url = {https://doi.org/10.11648/j.ijmi.20210902.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20210902.11},
  abstract = {Because the affected parts of some tumors and diseases are generally hidden, some are deeper, and the tissue structure is more complex and diverse, misdiagnosis and missed diagnosis are very easy to occur in the process of clinical diagnosis. In addition, the development of various diseases and tumors is closely related to the quality of life and prognosis of patients. Therefore, the diagnosis and treatment of diseases and monitoring after treatment are particularly important for patients. Ultrasound is easy to operate, non-invasive, and can be observed in real time. Ultrasound is the most used Frequent imaging diagnostic tools. In recent years, contrast-enhanced ultrasound (CEUS), as a newly developed imaging technology, has made important progress in ultrasound examination. In particular, the second-generation microbubble (MB) contrast agent in contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice. It can observe the whole process of organ and tumor microcirculation blood perfusion in real time and continuously, not only The morphological characteristics of the lesion can also provide the blood flow characteristics of the lesion, which improves the ability of the ultrasonic diagnostic instrument to display the blood flow in the lesion. Due to its non-invasiveness, real-time and safety, contrast-enhanced ultrasound technology provides safe, effective and valuable diagnostic and treatment options for ophthalmology, liver, gastrointestinal tract, heart, pediatrics and other fields. This article briefly reviews the origin and development of contrast agent ultrasound, basic principles, safety, the application of contrast-enhanced ultrasound in clinical diagnosis and treatment, and the advantages and disadvantages of contrast-enhanced ultrasound, and discusses its future development and limitations for pre-clinical surgery The qualitative diagnosis, selection of surgical methods and prognostic judgment and evaluation provide more accurate and comprehensive information in order to better serve and treat clinical diagnosis.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Application Advances of Contrast-enhanced Ultrasound in Clinical Diagnosis and Treatment
AU  - Zhou Xiaoyu
AU  - Peng Changfu
Y1  - 2021/04/23
PY  - 2021
N1  - https://doi.org/10.11648/j.ijmi.20210902.11
DO  - 10.11648/j.ijmi.20210902.11
T2  - International Journal of Medical Imaging
JF  - International Journal of Medical Imaging
JO  - International Journal of Medical Imaging
SP  - 98
EP  - 103
PB  - Science Publishing Group
SN  - 2330-832X
UR  - https://doi.org/10.11648/j.ijmi.20210902.11
AB  - Because the affected parts of some tumors and diseases are generally hidden, some are deeper, and the tissue structure is more complex and diverse, misdiagnosis and missed diagnosis are very easy to occur in the process of clinical diagnosis. In addition, the development of various diseases and tumors is closely related to the quality of life and prognosis of patients. Therefore, the diagnosis and treatment of diseases and monitoring after treatment are particularly important for patients. Ultrasound is easy to operate, non-invasive, and can be observed in real time. Ultrasound is the most used Frequent imaging diagnostic tools. In recent years, contrast-enhanced ultrasound (CEUS), as a newly developed imaging technology, has made important progress in ultrasound examination. In particular, the second-generation microbubble (MB) contrast agent in contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice. It can observe the whole process of organ and tumor microcirculation blood perfusion in real time and continuously, not only The morphological characteristics of the lesion can also provide the blood flow characteristics of the lesion, which improves the ability of the ultrasonic diagnostic instrument to display the blood flow in the lesion. Due to its non-invasiveness, real-time and safety, contrast-enhanced ultrasound technology provides safe, effective and valuable diagnostic and treatment options for ophthalmology, liver, gastrointestinal tract, heart, pediatrics and other fields. This article briefly reviews the origin and development of contrast agent ultrasound, basic principles, safety, the application of contrast-enhanced ultrasound in clinical diagnosis and treatment, and the advantages and disadvantages of contrast-enhanced ultrasound, and discusses its future development and limitations for pre-clinical surgery The qualitative diagnosis, selection of surgical methods and prognostic judgment and evaluation provide more accurate and comprehensive information in order to better serve and treat clinical diagnosis.
VL  - 9
IS  - 2
ER  -

Copy | Download